ICD-10 Coding for Adenoid Cystic Carcinoma(C08.0, C08.0B, C08.0M)
Learn about the ICD-10 coding for adenoid cystic carcinoma, including documentation requirements and clinical validation criteria.
Complete code families applicable to Adenoid Cystic Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C07 | Malignant neoplasm of parotid gland | Use when ACC is confirmed in the parotid gland. |
|
| C08.0 | Malignant neoplasm of submandibular gland | Use when ACC is confirmed in the submandibular gland. |
|
| C50.91 | Malignant neoplasm of unspecified site of female breast | Use when ACC is confirmed in the breast. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAdenoid Cystic Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Adenoid Cystic Carcinoma.
Using generic codes for specific sites
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding guidelines., Financial: Potential for claim denials.
Mitigation
Educate staff on site-specific coding, Use decision support tools
Confusing ACC with other salivary gland carcinomas
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Misclassification affects compliance with coding standards., Data Quality: Impacts accuracy of cancer registry data.
Mitigation
Ensure biopsy and immunohistochemical confirmation of ACC.
Site documentation
Impact
Lack of specific site documentation can lead to audit findings.
Mitigation
Implement mandatory site documentation checks.